8月20日,梅斯健康(02415)发布公告,公司预计上半年归母净利润不低于1000万元,去年同期归母净利润为20万元。
公司上半年利润增长主要由于:制药行业复苏,国内制药企业对循证驱动型营销模式的加速转型,带动精准全渠道营销解决方案需求增长;人工智能应用赋能提升本集团各业务分部生产效率;积极实施环境、社会及管治原则,从而更有效控制运营成本。
(文章来源:财中社)
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.